Apex Biotechnology (TPE:1733) 3-Year EBITDA Growth Rate : -7.30% (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology 3-Year EBITDA Growth Rate?

Apex Biotechnology's EBITDA per Share for the three months ended in Dec. 2024 was NT$0.61.

During the past 12 months, Apex Biotechnology's average EBITDA Per Share Growth Rate was 0.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Apex Biotechnology was 16.00% per year. The lowest was -31.40% per year. And the median was -6.80% per year.

Competitive Comparison of Apex Biotechnology's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Apex Biotechnology's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apex Biotechnology's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Apex Biotechnology 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Apex Biotechnology (TPE:1733) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Apex Biotechnology 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in the research, development, production, manufacturing, and selling of biochemical testing instruments and detection strips, and the trade of products and components relevant to the core business. Its products offer Diabetes Care, Home Diagnostics, and Point-of-Care Clinical and Laboratory. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, and HemoSmart GOLD hemoglobin screening system among others. Company operates in Taiwan, USA, Italy, Austria, China , Others. Majority of revenue is from USA.

Apex Biotechnology Headlines

No Headlines